These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 9210372)

  • 41. Activation of Jak-Stat and MAPK2 pathways by oncostatin M leads to growth inhibition of human glioma cells.
    Halfter H; Friedrich M; Postert C; Ringelstein EB; Stögbauer F
    Mol Cell Biol Res Commun; 1999 May; 1(2):109-16. PubMed ID: 10356359
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-alpha inhibits Stat5 DNA-binding in IL-2 stimulated primary T-lymphocytes.
    Erickson S; Matikainen S; Thyrell L; Sangfelt O; Julkunen I; Einhorn S; Grandér D
    Eur J Biochem; 2002 Jan; 269(1):29-37. PubMed ID: 11784295
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Interleukin-7 can induce the activation of Jak 1, Jak 3 and STAT 5 proteins in murine T cells.
    Foxwell BM; Beadling C; Guschin D; Kerr I; Cantrell D
    Eur J Immunol; 1995 Nov; 25(11):3041-6. PubMed ID: 7489741
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.
    Lejeune D; Demoulin JB; Renauld JC
    Biochem J; 2001 Jan; 353(Pt 1):109-116. PubMed ID: 11115404
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IL-2 unresponsiveness in anergic CD4+ T cells is due to defective signaling through the common gamma-chain of the IL-2 receptor.
    Grundström S; Dohlsten M; Sundstedt A
    J Immunol; 2000 Feb; 164(3):1175-84. PubMed ID: 10640728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. STAT5 activation is required for interleukin-9-dependent growth and transformation of lymphoid cells.
    Demoulin JB; Uyttenhove C; Lejeune D; Mui A; Groner B; Renauld JC
    Cancer Res; 2000 Jul; 60(14):3971-7. PubMed ID: 10919676
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interleukin 2 signaling involves the phosphorylation of Stat proteins.
    Frank DA; Robertson MJ; Bonni A; Ritz J; Greenberg ME
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7779-83. PubMed ID: 7544001
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CIS associates with the interleukin-2 receptor beta chain and inhibits interleukin-2-dependent signaling.
    Aman MJ; Migone TS; Sasaki A; Ascherman DP; Zhu Mh; Soldaini E; Imada K; Miyajima A; Yoshimura A; Leonard WJ
    J Biol Chem; 1999 Oct; 274(42):30266-72. PubMed ID: 10514520
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Alterations in T-cell signal transduction molecules associated with recurrent spontaneous pregnancy loss.
    Taylor DD; Gercel-Taylor C
    J Reprod Immunol; 2004 Oct; 63(2):137-54. PubMed ID: 15380944
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Signalling by cytokines interacting with the interleukin-2 receptor gamma chain.
    Demoulin JB; Renauld JC
    Cytokines Cell Mol Ther; 1998 Dec; 4(4):243-56. PubMed ID: 10068058
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of IL-2-induced T cell proliferation and phosphorylation of STAT3 and STAT5 by tumor-derived TGF beta is reversed by IL-15.
    Campbell JD; Cook G; Robertson SE; Fraser A; Boyd KS; Gracie JA; Franklin IM
    J Immunol; 2001 Jul; 167(1):553-61. PubMed ID: 11418694
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Requirement for distinct Janus kinases and STAT proteins in T cell proliferation versus IFN-gamma production following IL-12 stimulation.
    Ahn HJ; Tomura M; Yu WG; Iwasaki M; Park WR; Hamaoka T; Fujiwara H
    J Immunol; 1998 Dec; 161(11):5893-900. PubMed ID: 9834069
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Differential activation of signal transducer and activator of transcription (STAT)3 and STAT5 and induction of suppressors of cytokine signalling in T(h)1 and T(h)2 cells.
    Anderson P; Sundstedt A; Li L; O'Neill EJ; Li S; Wraith DC; Wang P
    Int Immunol; 2003 Nov; 15(11):1309-17. PubMed ID: 14565929
    [TBL] [Abstract][Full Text] [Related]  

  • 54. An alternative pathway for STAT activation that is mediated by the direct interaction between JAK and STAT.
    Fujitani Y; Hibi M; Fukada T; Takahashi-Tezuka M; Yoshida H; Yamaguchi T; Sugiyama K; Yamanaka Y; Nakajima K; Hirano T
    Oncogene; 1997 Feb; 14(7):751-61. PubMed ID: 9047382
    [TBL] [Abstract][Full Text] [Related]  

  • 55. TGF-beta inhibits IL-2-induced tyrosine phosphorylation and activation of Jak-1 and Stat 5 in T lymphocytes.
    Bright JJ; Kerr LD; Sriram S
    J Immunol; 1997 Jul; 159(1):175-83. PubMed ID: 9200453
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interleukin-2 induces tyrosine phosphorylation and nuclear translocation of stat3 in human T lymphocytes.
    Nielsen M; Svejgaard A; Skov S; Odum N
    Eur J Immunol; 1994 Dec; 24(12):3082-6. PubMed ID: 7528668
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Staphylococcal enterotoxins modulate interleukin 2 receptor expression and ligand-induced tyrosine phosphorylation of the Janus protein-tyrosine kinase 3 (Jak3) and signal transducers and activators of transcription (Stat proteins).
    Nielsen M; Svejgaard A; Röpke C; Nordahl M; Odum N
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10995-9. PubMed ID: 7479924
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defective IL-2-mediated IL-2 receptor alpha chain expression in Stat3-deficient T lymphocytes.
    Akaishi H; Takeda K; Kaisho T; Shineha R; Satomi S; Takeda J; Akira S
    Int Immunol; 1998 Nov; 10(11):1747-51. PubMed ID: 9846704
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The T cell protein tyrosine phosphatase is a negative regulator of janus family kinases 1 and 3.
    Simoncic PD; Lee-Loy A; Barber DL; Tremblay ML; McGlade CJ
    Curr Biol; 2002 Mar; 12(6):446-53. PubMed ID: 11909529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. UL16-binding proteins, novel MHC class I-related proteins, bind to NKG2D and activate multiple signaling pathways in primary NK cells.
    Sutherland CL; Chalupny NJ; Schooley K; VandenBos T; Kubin M; Cosman D
    J Immunol; 2002 Jan; 168(2):671-9. PubMed ID: 11777960
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.